Board Meeting25 May 2026, 06:21 pm
Chandra Bhagat Pharma Approves Audited Results for FY26
AI Summary
Chandra Bhagat Pharma Ltd's Board of Directors approved the audited financial results for the year ended March 31, 2026, during their meeting held on May 25, 2026. The audit report, furnished by the statutory auditor, had an unmodified opinion. The trading window for the company's shares will open 48 hours after the announcement of the financial statement.
Key Highlights
- Audited financial results for FY26 approved by the board.
- Auditor's report for FY26 has an unmodified opinion.
- Trading window to open 48 hours post financial statement announcement.
- Meeting held as per SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Price Impact
More from CBPL